Ross DD - Search Results

1

Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE. Robey RW, et al. Among authors: ross dd. Clin Cancer Res. 2001 Jan;7(1):145-52. Clin Cancer Res. 2001. PMID: 11205902

2

The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).

Litman T, Brangi M, Hudson E, Fetsch P, Abati A, Ross DD, Miyake K, Resau JH, Bates SE. Litman T, et al. Among authors: ross dd. J Cell Sci. 2000 Jun;113 ( Pt 11):2011-21. doi: 10.1242/jcs.113.11.2011. J Cell Sci. 2000. PMID: 10806112

3

The role of half-transporters in multidrug resistance.

Bates SE, Robey R, Miyake K, Rao K, Ross DD, Litman T. Bates SE, et al. Among authors: ross dd. J Bioenerg Biomembr. 2001 Dec;33(6):503-11. doi: 10.1023/a:1012879205914. J Bioenerg Biomembr. 2001. PMID: 11804192 Review.

4

Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.

Rajendra R, Gounder MK, Saleem A, Schellens JH, Ross DD, Bates SE, Sinko P, Rubin EH. Rajendra R, et al. Among authors: ross dd. Cancer Res. 2003 Jun 15;63(12):3228-33. Cancer Res. 2003. PMID: 12810652

5

Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD. Chen ZS, et al. Among authors: ross dd. Cancer Res. 2003 Jul 15;63(14):4048-54. Cancer Res. 2003. PMID: 12874005

6

Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors.

Garimella TS, Ross DD, Eiseman JL, Mondick JT, Joseph E, Nakanishi T, Bates SE, Bauer KS. Garimella TS, et al. Among authors: ross dd. Cancer Chemother Pharmacol. 2005 Feb;55(2):101-9. doi: 10.1007/s00280-004-0866-2. Epub 2004 Oct 1. Cancer Chemother Pharmacol. 2005. PMID: 15580504

7

Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients.

Nakanishi T, Karp JE, Tan M, Doyle LA, Peters T, Yang W, Wei D, Ross DD. Nakanishi T, et al. Among authors: ross dd. Clin Cancer Res. 2003 Aug 15;9(9):3320-8. Clin Cancer Res. 2003. PMID: 12960118

8

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.

Nakanishi T, Bailey-Dell KJ, Hassel BA, Shiozawa K, Sullivan DM, Turner J, Ross DD. Nakanishi T, et al. Among authors: ross dd. Cancer Res. 2006 May 15;66(10):5007-11. doi: 10.1158/0008-5472.CAN-05-4572. Cancer Res. 2006. PMID: 16707421

9

H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein.

Doyle LA, Yang W, Rishi AK, Gao Y, Ross DD. Doyle LA, et al. Among authors: ross dd. Cancer Res. 1996 Jul 1;56(13):2904-7. Cancer Res. 1996. PMID: 8674037

10

Thapsigargin resistance in human prostate cancer cells.

O'Neill JP, Velalar CN, Lee DI, Zhang B, Nakanishi T, Tang Y, Selaru F, Ross D, Meltzer SJ, Hussain A. O'Neill JP, et al. Cancer. 2006 Aug 1;107(3):649-59. doi: 10.1002/cncr.22027. Cancer. 2006. PMID: 16770788 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters